http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100327762-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-15 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-73 |
| filingDate | 2000-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2002-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100327762-B1 |
| titleOfInvention | Novel extract from Agrimonia pilosa L. inhibiting synthesis of surface antigen of hepaptitis B virus, process for preparation the same and the use thereof |
| abstract | The present invention relates to a substance for inhibiting the surface antigen production of hepatitis B virus isolated from plant A. a . Phenolosa L. starch, an isolation method thereof, and a hepatitis and liver cancer therapeutic agent of the isolated hepatitis B virus surface antigen production inhibitor. The present invention relates to the use as a natural plant, Agrimonia pilosa L. When a natural crushed dry ground crushed powder is mixed with distilled water and fermented, and extracted with a water-soluble solvent such as acetone, dimethylformamide or propanol. Hepatitis B virus, which is a substance obtained from the sediment of hepatitis B, inhibits the surface antigen production of hepatitis B virus in the hepatitis B cell line PLC / PRF / 5 cell line containing hepatitis B virus genome. It works. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021095921-A1 |
| priorityDate | 2000-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 98.